Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of liver disease: why and how.
Macpherson I, Abeysekera KWM, Harris R, Mansour D, McPherson S, Rowe I, Rosenberg W, Dillon JF, Yeoman A; Specialist Interest Group in the Early Detection of Liver Disease Members. Macpherson I, et al. Among authors: rosenberg w. Frontline Gastroenterol. 2022 Jan 24;13(5):367-373. doi: 10.1136/flgastro-2021-101833. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36051960 Free PMC article. Review.
Development of a decision support tool to facilitate primary care management of patients with abnormal liver function tests without clinically apparent liver disease [HTA03/38/02]. Abnormal Liver Function Investigations Evaluation (ALFIE).
Donnan PT, McLernon D, Steinke D, Ryder S, Roderick P, Sullivan FM, Rosenberg W, Dillon JF. Donnan PT, et al. Among authors: rosenberg w. BMC Health Serv Res. 2007 Apr 16;7:54. doi: 10.1186/1472-6963-7-54. BMC Health Serv Res. 2007. PMID: 17437630 Free PMC article.
Development of a decision support tool for primary care management of patients with abnormal liver function tests without clinically apparent liver disease: a record-linkage population cohort study and decision analysis (ALFIE).
Donnan PT, McLernon D, Dillon JF, Ryder S, Roderick P, Sullivan F, Rosenberg W. Donnan PT, et al. Among authors: rosenberg w. Health Technol Assess. 2009 Apr;13(25):iii-iv, ix-xi, 1-134. doi: 10.3310/hta13250. Health Technol Assess. 2009. PMID: 19413926 Free article.
Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon α-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis.
Tanwar S, Wright M, Foster GR, Ryder SD, Mills PR, Cramp ME, Parkes J, Rosenberg WM. Tanwar S, et al. Eur J Gastroenterol Hepatol. 2012 May;24(5):543-50. doi: 10.1097/MEG.0b013e3283513e69. Eur J Gastroenterol Hepatol. 2012. PMID: 22337287 Clinical Trial.
301 results